Editorial: Endocrine Abnormalities and Renal Complications

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Sep 6

PMID 37670892

Authors

Anil Kumar Pasupulati

Sreenivasulu Kilari

Manisha Sahay

Affiliations

Soon will be listed here.

References

. Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2014; 3(1):19-62. PMC: 4089693. DOI: 10.1038/kisup.2012.64. View

Waziri B, Duarte R, Naicker S . Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives. Int J Nephrol Renovasc Dis. 2020; 12:263-276. PMC: 6935280. DOI: 10.2147/IJNRD.S191156. View

. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225):709-733. PMC: 7049905. DOI: 10.1016/S0140-6736(20)30045-3. View

Nishad R, Mukhi D, Kethavath S, Raviraj S, Paturi A, Motrapu M . Podocyte derived TNF-α mediates monocyte differentiation and contributes to glomerular injury. FASEB J. 2022; 36(12):e22622. DOI: 10.1096/fj.202200923R. View

Haffner D, Grund A, Leifheit-Nestler M . Renal effects of growth hormone in health and in kidney disease. Pediatr Nephrol. 2021; 36(8):2511-2530. PMC: 8260426. DOI: 10.1007/s00467-021-05097-6. View

Benedetti V, Lavecchia A, Locatelli M, Brizi V, Corna D, Todeschini M . Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes. JCI Insight. 2019; 4(18). PMC: 6795387. DOI: 10.1172/jci.insight.130249. View

Coimbra S, Rocha S, Valente M, Catarino C, Bronze-da-Rocha E, Belo L . New Insights into Adiponectin and Leptin Roles in Chronic Kidney Disease. Biomedicines. 2022; 10(10). PMC: 9599100. DOI: 10.3390/biomedicines10102642. View

Anil Kumar P, Kotlyarevska K, Dejkhmaron P, Reddy G, Lu C, Bhojani M . Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy. J Biol Chem. 2010; 285(41):31148-56. PMC: 2951188. DOI: 10.1074/jbc.M110.132332. View

Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J . Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. Nutrients. 2021; 13(9). PMC: 8472557. DOI: 10.3390/nu13093138. View

10.

Nishad R, Mukhi D, Singh A, Motrapu M, Chintala K, Tammineni P . Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021; 12(4):342. PMC: 8016968. DOI: 10.1038/s41419-021-03643-6. View

11.

. Section 2: AKI Definition. Kidney Int Suppl (2011). 2014; 2(1):19-36. PMC: 4089595. DOI: 10.1038/kisup.2011.32. View

12.

Zoccali C, Vanholder R, Massy Z, Ortiz A, Sarafidis P, Dekker F . The systemic nature of CKD. Nat Rev Nephrol. 2017; 13(6):344-358. DOI: 10.1038/nrneph.2017.52. View

13.

Ma H, Chen S, Du Y . Estrogen and estrogen receptors in kidney diseases. Ren Fail. 2021; 43(1):619-642. PMC: 8018493. DOI: 10.1080/0886022X.2021.1901739. View

14.

Portoles J, Martin L, Broseta J, Cases A . Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents. Front Med (Lausanne). 2021; 8:642296. PMC: 8032930. DOI: 10.3389/fmed.2021.642296. View

15.

Mukhi D, Kolligundla L, Maruvada S, Nishad R, Pasupulati A . Growth hormone induces transforming growth factor-β1 in podocytes: Implications in podocytopathy and proteinuria. Biochim Biophys Acta Mol Cell Res. 2022; 1870(2):119391. DOI: 10.1016/j.bbamcr.2022.119391. View